Ionis Pharmaceuticals Inc
F:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
M
|
Minesto AB
XMUN:7MN
|
SE |
|
A
|
AMP Ltd
F:AMP
|
AU |
|
P
|
Palfinger AG
XMUN:PFI
|
AT |
|
H
|
Honda Motor Co Ltd
SWB:HDM
|
JP |
|
T
|
Textron Inc
F:TXT
|
US |
|
Trigano SA
F:TGO
|
FR |
|
Banco do Brasil SA
OTC:BDORY
|
BR |
|
A
|
Aramark
F:0AK
|
US |
|
Panin Financial Tbk PT
IDX:PNLF
|
ID |
|
L
|
LEG Immobilien SE
F:LEG
|
DE |
|
G
|
Gaming and Leisure Properties Inc
F:2GL
|
US |
|
C
|
Chalice Mining Ltd
XBER:C8U
|
AU |
|
C
|
Cognex Corp
XMUN:CGZ
|
US |
|
Inogen Inc
NASDAQ:INGN
|
US |
|
C
|
Continental AG
XMUN:CON
|
DE |
|
Barito Pacific Tbk PT
F:OB8
|
ID |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ISI is 79.81 EUR with a low forecast of 35.49 EUR and a high forecast of 104.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
79.81
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 79.81 EUR with a low forecast of 35.49 EUR and a high forecast of 104.27 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 26%.
What is the Gross Profit forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
